The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.
D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents; D007958:Leukocyte Count; D008214:Lymphocytes / Q000187:drug effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000276:immunology; D008875:Middle Aged; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D014751:Vindesine
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D014747:Vinblastine; D014751:Vindesine